# reload+after+2024-01-21 14:45:00.956974
address1§Joshua Dawson House
address2§Dawson Street
city§Dublin
zip§D02 RY95
country§Ireland
phone§353 1 437 8334
website§https://www.ghres.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies to treat psychiatric and neurological disorders. The company develops 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable mebufotenin product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an intravenous mebufotenin product candidate; and GH003, an intranasal mebufotenin product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.
fullTimeEmployees§32
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Florian  Schonharting M.Sc. (Econ)', 'age': 54, 'title': 'Co-Founder & Non-Executive Chairman of the Board', 'yearBorn': 1969, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Theis  Terwey M.D.', 'age': 47, 'title': 'Co-Founder & CEO', 'yearBorn': 1976, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Magnus  Halle', 'age': 26, 'title': 'Co-Founder & MD of Ireland', 'yearBorn': 1997, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Julie  Ryan F.C.A.', 'age': 37, 'title': 'Vice President of Finance', 'yearBorn': 1986, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Naoise  Gaffney', 'title': 'VP & Head of Intellectual Property', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Aaron  Cameron M.B.A.', 'age': 38, 'title': 'Vice President of Technical Development & Operational Planning', 'yearBorn': 1985, 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.667
currency§USD
dateShortInterest§1702598400
forwardEps§-0.94
exchange§NGM
quoteType§EQUITY
shortName§GH Research PLC
longName§GH Research PLC
firstTradeDateEpochUtc§1624627800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§c55fe4aa-a267-3808-8a6d-44adac7d7d7b
gmtOffSetMilliseconds§-18000000
targetHighPrice§50.0
targetLowPrice§18.0
targetMeanPrice§34.5
targetMedianPrice§35.0
recommendationMean§1.8
recommendationKey§buy
numberOfAnalystOpinions§4
quickRatio§26.292
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
